Works cited GLP-1 Analogues Market Size & Growth Forecast to 2033 MarketsandMarkets, accessed February 2, 2026, GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market Global Forecast to 2033: With the Semaglutide Patent Expiring in 2026 Onwards, the Biosimilars Market is Expected to Grow Significantly GlobeNewswire, accessed February 2, 2026, GLP-1 Receptor Agonists and Patent Strategy: Securing Patent , accessed February 2, 2026, Are GLP-1s about to dethrone oncology as pharmas biggest segment
10.1016/j.ajo.2022.01.020 37 VanDerMeidK
14,15 Because of the results of these landmark clinical trials, evidence-based treatment guidelines now recommend the GLP-1/GIP agonists as an important second-line treatment for uncomplicated type 2 diabetics who fail to meet hemoglobin A1c targets on popular first-line agents such as metformin
doi: 10.1016/j.ijcard.2011.12.079 50 KlatskyALFriedmanGDSidneySKippHKuboAArmstrongMA
New 10mg/vial $60.49 Select Size Also available in other sizes Same compound, same 99% purity choose the quantity that fits your research